Activity of a Novel Hec1-Targeted Anticancer Compound against Breast Cancer Cell Lines In Vitro and In Vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activity of a Novel Hec1-Targeted Anticancer Compound against Breast Cancer Cell Lines In Vitro and In Vivo

Published:2014-04-02 Issue:6 Volume:13 Page:1419-1430
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Huang Lynn Y.L.,Chang Chia-Chi,Lee Ying-Shuan,Chang Jia-Ming,Huang Jiann-Jyh,Chuang Shih-Hsien,Kao Kuo-Jang,Lau Gillian M.G.,Tsai Pei-Yi,Liu Chia-Wei,Lin Her-Sheng,Lau Johnson Y.N.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro and In Vivo Effects of Docetaxel and Dasatinib in Triple-Negative Breast Cancer: A Research Study;Cureus;2023-08-15

2. Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development;Molecules;2022-01-06

3. Increased SPC24 in prostatic diseases and diagnostic value of SPC24 and its interacting partners in prostate cancer;Experimental and Therapeutic Medicine;2021-06-30

4. NEK2 regulates cellular proliferation and cabergoline sensitivity in pituitary adenomas;Journal of Cancer;2021

5. Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy;European Journal of Medicinal Chemistry;2020-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP